CURAXIS PHARMACEUTICAL CORP Proceeds from Common Stock Issued
CURAXIS PHARMACEUTICAL CORP reported Proceeds from Common Stock Issued of $54.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for the quarter ending 2012-03-31 was $54.00K, a 60.29% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for the quarter ending 2011-12-31 was $97.00K, a 438.89% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for the quarter ending 2011-09-30 was $170.00K, a 246.94% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for the quarter ending 2011-06-30 was $105.00K.
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for fiscal 2011 was $508.00K, a 86.76% increase from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP proceeds from issuance of common stock for fiscal 2010 was $272.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 41 month | Proceeds from Issuance of Common Stock 127 month | Proceeds from Issuance of Common Stock 130 month | Proceeds from Issuance of Common Stock 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $54.00K 10-Q · filed 2012-05-14 | $151.00K derived: sum of 2 quarters · filed 2012-05-14 | $321.00K derived: sum of 3 quarters · filed 2012-05-14 | $426.00K derived: sum of 4 quarters · filed 2012-05-14 | $75.32M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $267.00K derived: sum of 2 quarters · filed 2012-03-29 | $372.00K derived: sum of 3 quarters · filed 2012-03-29 | $508.00K 10-K · filed 2012-03-29 | $75.27M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $275.00K derived: sum of 2 quarters · filed 2011-11-10 | $411.00K 10-Q · filed 2011-11-10 | $429.00K derived: sum of 4 quarters · filed 2012-05-14 | $75.17M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | $241.00K 10-Q · filed 2011-08-12 | $259.00K derived: sum of 3 quarters · filed 2012-05-14 | $308.00K derived: sum of 4 quarters · filed 2012-05-14 | $75.00M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $136.00K 10-Q · filed 2012-05-14 | $154.00K derived: sum of 2 quarters · filed 2012-05-14 | $203.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $67.00K derived: sum of 2 quarters · filed 2012-03-29 | $272.00K 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $254.00K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | $205.00K 10-Q · filed 2011-08-12 |